Decoy Therapeutics Inc. insider trading

DCOYNASDAQ

$1.77-0.09 (-4.58%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-96.4%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25

Unlock quarterly net flow

Key players

FPFrederick Pierce IIChief Executive Officer5.3182%of company
MJMark J. RosenblumChief Financial Officer1.7343%of company
BLBarbara Louise HibnerChief Scientific Officer0.6435%of company
PKPeter Klaus MarschelChief Business Officer0.5953%of company
ACArnold C. HanishDirector0.5217%of company
WKWilliam K. McVicarDirector0.4582%of company
JIJonathan I. LieberDirector0.3056%of company
TBTess BurlesonDirector0.3056%of company
PLPaul LammersDirector0.3054%of company
PGPatricia G. GauthierDirector0.3053%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
DCOY	Arnold C. HanishDirector	Open market sell$7.7	-0.2%	$0.64	$7.7	Dec 30, 2025	Jan 2, 2026
DCOY	Arnold C. HanishDirector	Open market sell$9.6	-0.3%	$0.64	$9.6	Dec 30, 2025	Jan 2, 2026
DCOY	Arnold C. HanishDirector	Open market purchase$3.75K	+18518.5%	$0.75	$3.75K	Nov 20, 2025	Nov 24, 2025
DCOY	Mark J. RosenblumExec VP Finance, CFO	Open market purchase$16K	+11299.4%	$0.80	$16K	Nov 20, 2025	Nov 20, 2025

End of history · 4 transactions